Search Tag: Accelerate Diagnostics

ICU Management

HHFT pioneers use of diagnostic tools for earlier optimisation for sepsis patients

2018 08 May

… Antimicrobial Susceptibility Testing (AST) times reduced from days to hours….   Hampshire Hospitals NHS Foundation Trust (HHFT) is pioneering the use of the Accelerate Pheno TM system from Accelerate Diagnostics, Inc., (Accelerate Diagnostics) a leading in vitro diagnostics company, to speed up and improve the diagnostic outcome of antibiotic... Read more

ICU Management

Hospital de La Princesa shortens antibiotic adaptation treatment for severe sepsis

2018 08 May

In positive blood cultures, the Accelerate Pheno TM system identifies the agent causing the infection in 90 minutes and around 5 hours afterwards it provides information on the antibiotic sensitivity of the pathogen, which is 28 hours less than the current conventional system used in the La Princesa Hospital.  Two studies carried out by the centre, which... Read more

ICU Management

Volume 18 - Issue 1, 2018

2018 16 Mar

Change content default value Read more

ICU Management

Improving diagnostic stewardship by using new microbiological technologies

2018 16 Mar

Describes an episode of sepsis in a leukaemia patient, whose treatment was early guided by using rapid diagnostics technology to identify the cause of infection. A 4-year-old patient under treatment for acute lymphoblastic leukaemia, diagnosed 6 months before, was admitted to the emergency room (ER) at midnight (00h33) due to a fever episode... Read more

ICU Management

Sepsis code implementation at Vall d’Hebron University Hospital: rapid diagnostics key to success

2017 22 Nov

Implementation of a sepsis code, Código Sepsis, in October 2015 at the Vall d’Hebron University Hospital in Barcelona has led to better detection and a significant reduction in mortality. The hospital is the largest in Barcelona, with more than 1,100 beds and 7,000 employees. The objectives of Código Sepsis are to increase suspicion of sepsis and... Read more

ICU Management

Accelerate Diagnostics welcomes Dr. Romney Humphries as Chief Scientific Officer

2017 15 Sep

Accelerate Diagnostics, Inc. has announced the addition of Romney Humphries, PhD, D(ABMM), M(ASCP) to its executive management team as Chief Scientific Officer.   Dr. Romney Humphries comes to Accelerate from UCLA Medical Center where she was the Section Chief for Clinical Microbiology and the Assistant Clinical Professor of the Department of Pathology... Read more

ICU Management

Accelerate Diagnostics Announces Sizeable Release of Data at ASM Microbe 2017

2017 30 May

Accelerate Diagnostics, Inc. has announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at the upcoming annual meeting of the American Society for Microbiology – ASM Microbe in New Orleans, LA. The data comes from external studies that evaluated the potential clinical and workflow benefits of the... Read more

ICU Management

Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering

2017 15 May

Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $28.85 per share. The gross proceeds to Accelerate Diagnostics... Read more

ICU Management

Accelerate Diagnostics Reports 191 Instruments Under Contract & 3x Revenue Growth

2017 03 May

Accelerate Diagnostics, Inc. has announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating placements, and revenue growth exceeding 325% of the same period in the prior year. Net sales for the first... Read more